No Data
No Data
Express News | OS Therapies 2024 EPS $(0.88) May Not Be Comparable To $(1.46) YoY
OS Therapies | 10-K: Annual report
OS Therapies Provided A Regulatory Update For Its OST-HER2 Listeria Monocytogenes Immunotherapeutic Cancer Biologic Drug Candidate To Prevent Or Delay Fully-Resected, Recurrent, Lung Metastatic Osteosarcoma
Express News | Os Therapies - New Canine Elite Responder Biomarkers Added to Human Biomarker Strategy
Express News | Os Therapies - Dialogue Open With FDA in Preparation for End of Phase 2 Meeting Request
OS Therapies Announces OST-HER2 Feature In Movie Shelter Me: The Cancer Pioneers; Focus On Canine Comparative Oncology And Rare Cancer Treatments; Will Premiere April 3, 2025, Streaming On PBS In May 2025